【レポートの概要(一部)】
1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Stakeholders
1.3 Market Scope
1.4 Cancer Biomarkersmarkets Covered
2 Research Methodology (Page No. – 19)
2.1 Research Approach
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.4.1 Key Data From Secondary Sources
2.4.2 Key Data From Primary Sources
2.4.3 Key Industry Insights
2.5 Assumptions for the Study
3 Executive Summary (Page No. – 28)
4 Premium Insights (Page No. – 32)
5 Market Overview (Page No. – 33)
5.1 Introduction
5.2 Market Segmentation
5.2.1 Cancer Biomarkers Market, By Type
5.2.2 Cancer Biomarkers Market, By Tumor Type
5.2.3 Cancer Biomarkers Market, By Profiling Technologies
5.2.4 Cancer Biomarkers Market, By Application
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Technological Advancements
5.3.1.2 Increasing Prevalence of Cancer
5.3.1.3 Enhanced Accuracy and Speed of Diagnosis
5.3.1.4 Increasing Use of Cancer Biomarkers in Drug Discovery and Development
5.3.1.5 Increasing Research on Cancer Biomarkers
5.3.1.6 Fda Support for Biomarker Development
5.3.2 Restraints
5.3.2.1 Poorly Suited Regulatory and Reimbursement Systems
5.3.2.2 High Capital Investment and Low Benefit-Cost Ratio
5.3.2.3 Technical Issues Related to Sample Collection and Storage
5.3.3 Opportunitites
5.3.3.1 Personalized Medicine
5.3.3.2 Companion Diagnostics
5.3.3.3 Emerging Economies
5.3.4 Challenges
5.3.4.1 Proving Clinical Validity and Utility of Biomarker-Based Tests Leading to Their Insufficient Acceptance
6 Industry Trends (Page No. – 49)
6.1 Introduction
6.2 Industry Trends
6.2.1 Increasing Use of Bimarkers for Developing Personalized Medicine
6.2.2 Advancements in Omics Technologies
6.3 Porter’s Five Forces Analysis
6.3.1 Threat From New Entrants
6.3.2 Threat From Substitutes
6.3.3 Bargaining Power of Suppliers
6.3.4 Bargaining Power of Buyers
6.3.5 Intensity of Competitive Rivalry
6.4 Strategic Benchmarking
6.4.1 New Product Launches and Product Enhancements
7 By Tumor Type (Page No. – 55)
7.1 Introduction
7.2 Breast Cancer
7.3 Lung Cancer
7.4 Colorectal Cancer
7.5 Prostate Cancer
7.6 Cervical Cancer
7.7 Other Cancers
8 Cancer Biomarkers Market, By Type (Page No. – 61)
8.1 Introduction
8.2 Protein Biomarkers
8.3 Genetic Biomarkers
8.4 Other Cancer Biomarkers
9 By Profiling Technologies (Page No. – 64)
9.1 Introduction
9.2 Immunoassays
9.2.1 Elisa
9.2.2 Immunohistochemistry (IHC)
9.2.3 Flow Cytometry
9.3 Omics Technologies
9.3.1 Genomics
9.3.1.1 Next Generation Sequencing (NGS)
9.3.1.2 Microarrays
9.3.1.3 PCR (Polymer Chain Reaction)
9.3.2 Proteomics
9.3.2.1 Mass Spectrometry
9.3.2.1.1 Maldi Mass Spectrometry
9.3.2.1.2 Imaging Mass Spectrometry
9.3.2.2 2-D Gel Electrophoresis
9.3.2.3 Protein Microarray Technology
9.3.2.4 Antibody Array Technology
9.3.2.5 Peptide Array Technology
9.3.3 Other Omics Technologies
9.4 Cytogenetics
9.4.1 Ish (In Situ Hybridization)
9.4.2 Others
9.5 Imaging Technologies
9.5.1 Magnetic Resonance Imaging (MRI)
9.5.2 Positron Emission Tomography (PET)
9.5.3 Mammography
9.5.4 Computed Tomography (CT)
9.5.5 Ultrasound
9.6 Bioinformatics
10 By Application (Page No. – 88)
10.1 Introduction
10.2 Diagnostics
10.3 Drug Discovery and Development
10.4 Prognostics
10.5 Risk Assessment
10.6 Others
11 By Geographic Analysis (Page No. – 93)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe (RoE)
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia-Pacific (RoAPAC)
11.5 Rest of the World (RoW)
11.5.1 Latin America
11.5.2 Middle East and Africa
12 Competitive Landscape (Page No. – 130)
12.1 Overview
12.2 Market Share Analysis, Global Cancer Biomarkers Market
12.3 Competitive Situation and Trends
12.3.1 New Product Launches
12.3.2 Expansions
12.3.3 Agreements, Partnerships, Collaborations, & Joint Ventures
12.3.4 Mergers & Acquisitions
13 Company Profiles (Page No. – 140)
13.1 Introduction
13.2 Abbott Laboratories
13.2.1 Business Overview
13.2.2 Products Offered
13.2.3 MnM View
13.2.4 Recent Developments
13.3 Affymetrix, Inc.
13.3.1 Business Overview
13.3.2 Products Offered
13.3.3 MnM View
13.3.4 Recent Developments
13.4 Illumina, Inc.
13.4.1 Business Overview
13.4.2 Products Offered
13.4.3 MnM View
13.4.4 Recent Developments
13.5 Qiagen N.V.
13.5.1 Business Overview
13.5.2 Qiagen N.V.: Company Snapshot
13.5.3 Products Offered
13.5.4 MnM View
13.5.5 Recent Developments
13.6 Roche Diagnostics Ltd.
13.6.1 Business Overview
13.6.2 Products Offered
13.6.3 MnM View
13.6.4 Recent Developments
13.7 Agilent Technologies, Inc.
13.7.1 Business Overview
13.7.2 Products Offered
13.7.3 MnM View
13.7.4 Recent Developments
13.8 Quest Diagnostics Inc.
13.8.1 Business Overview
13.8.2 Quest Diagnostics: Company Snapshot
13.8.3 Products Offered
13.8.4 Recent Developments
13.9 Merck & Co. Inc.
13.9.1 Business Overview
13.9.2 Products Offered
13.9.3 Recent Developments
13.10 Hologic, Inc.
13.10.1 Business Overview
13.10.2 Products Offered
13.10.3 Recent Developments
13.11 Becton, Dickinson and Company
13.11.1 Business Overview
13.11.2 Product Portfolio
13.11.3 Developmets
14 Appendix (Page No. – 167)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Available Customizations
14.4 Related Reports
14.5 Introducing RT: Real-Time Market Intelligence
【レポート販売概要】
■ タイトル:癌バイオマーカーの世界市場:タンパク質バイオマーカー、ジェネティックバイオマーカー■ 英文:Cancer Biomarkers Market by Tumor (Breast, Lung, Prostate), Type (Protein & Genetic Biomarkers), Profiling Technology (Proteomics, Genomics, Imaging, Immunoassay), Application (Diagnostic, Drug Discovery, Prognostic) & Geography - Global Forecast to 2020
■ 発行日:2015年8月28日
■ 調査会社:MarketsandMarkets
■ 商品コード:MAM-BT-3693
■ 調査対象地域:グローバル
- 電着塗装の世界市場:陰極エポキシ塗料、陰極アクリル塗料、陽極エポキシ塗料、陽極アクリル塗料The report covers the e-coat market and further segments the market on the basis of type, application, and region. The market data for these types is given with respect to volume (Million Square Meter) and value (USD million). The market size, in terms of value, of e-coat is estimated to be USD 2.87 billion in 2015 and is projected to register a CAGR of about 5.12% between 2015 and 2020. The data …
- 世界のPUソール(フットウェアポリウレタン)市場:原材料別(メチレンジフェニルジイソシアネート、トルエンジフェニルジイソシアネート、およびポリオール)、用途別(カジュアル、ブーツ、スリッパ、サンダル、スポーツ、フォーマル)、地域別“The global PU sole (footwear polyurethane) market is projected to witness a CAGR of 7.6% during the forecast period.” The PU sole (footwear polyurethane) market size was estimated at USD 4.2 billion in 2019 and is projected to reach USD 5.9 billion by 2024, at a CAGR of 7.6%. The high growth is attributed to the growth of the footwear industry, which is characterized by changing fashion and lifes …
- グローバルパッケージング産業の景況感レポート(2015年上半期)Summary “Packaging Business Confidence Report H1 2015” is a new report by Canadean that globally analyzes industry opinions on the latest economic and consumer issues, and their impact on investment decisions and growth prospects within the packaging industry. This report also examines executive opinion about the current and future state of the economy, and its retrospective effect on the industry …
- 運動失調(Ataxia):グローバル臨床試験レビュー(2014年上半期)Ataxia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Ataxia Global Clinical Trials Review, H1, 2014" provides data on the Ataxia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ataxia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction ac …
- 近接センサの世界市場:誘導形、静電容量形、磁気式、光電式、超音波式The proximity sensor market report covers the industries such as aerospace & defense, automotive, food & beverage, pharmaceuticals, consumer electronics, building automation, industrial manufacturing, geography such as North America (U.S., Canada, and Mexico), Europe (Germany, U.K., France, Italy, and Others), Asia-Pacific (China, Japan, India, South Korea, and Others) and Rest of the World (Middl …
- 3D半導体パッケージングの世界市場2016-2020About the 3D Semiconductor Packaging Market Recent technology advances along with improved durability, reduced energy consumption, superior performance, enhanced quality, and highly efficient features of 3D semiconductor packaging equipment are making this equipment attractive packaging proposition in the semiconductor industry, especially in the consumer electronics industry. The increasing deman …
- 心臓バイオマーカーの世界市場:トロポニン、BNP/NT-proBNP、CK-MB、ミオグロビンAbout Cardiac Biomarker A cardiac biomarker is defined as a measurable substance that is an indicator used in the diagnosis and risk stratification related to cardiovascular disease (CVDs) such as acute coronary syndrome (ACS), coronary syndromes, myocardial infarction (MI), and heart failure. Some of the cardiac biomarkers include creatine kinase (CK) MB, troponins (cTnI and cTnT), BNP, NT-proBNP …
- クラウドアプリケーションマーケットプレイス(Cloud Application Marketplace 2012 – 2017)The global cloud applications marketplace is driven largely by the increasing adoption of a variety of mobile devices including smartphones, iPhones, iPads, tablets PCs and ultrabooks. Mobile device penetration and usage drives application demand with the latter indicating a strong correlation with cloud adoption rates. This trend is expected to accelerate as the lower cost of cloud application op …
- ログ管理の世界市場予測(~2022年):ソリューション、サービス“Increasing Advanced Persistent Threats (APTs) is expected to drive the log management market.”The log management market size is expected to grow from USD 707 million in 2017 to USD 1,248.9 million by 2022, at a Compound Annual Growth Rate (CAGR) of 12.1%. The log management market is driven by various factors, such as increasing APTs, strong regulation and compliance requirements, and increasing …
- BRIC新興国の心臓補助処置動向(~2020)BRIC Cardiac Assist Procedures Outlook to 2020 Summary GlobalData’s new report, "BRIC Cardiac Assist Procedures Outlook to 2020", provides key procedures data on the BRIC Cardiac Assist Procedures. The report provides procedure volumes within market categories – Total Artificial Heart (TAH) Procedures and Ventricular Assist Procedures (Left Ventricular, Right Ventricular, External Ventricular and …
- プロラクチンの市場別医療検査数および販売予測This new report from Venture Planning Group provides analysis of Prolactin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories P …
- 医療機器3Dプリンティングの世界市場:3Dプリンター、3Dバイオプリンター、材料、サービス、ソフトウェアThe global 3D printing medical devices market is estimated to grow at a CAGR of 25.3% from 2015 to 2020. Although developed countries (such as the U.S., Germany, and the U.K.) hold larger shares in the 3D printing medical devices market, the Asia-Pacific region is poised to witness the highest CAGR in the coming five years. Factors such as the presence of a large patient population, increasing eff …
- 2014年戦略提言:世界の整形外科市場This report provides a worldwide strategic overview of the orthopedics market, including forecasts for major geographic regions, market segments and product categories.In addition, the report presents a concise review of the major U.S. and international trends with potentially significant impact on the orthopedics market during the next five years, including industry consolidation, market globaliz …
- DMS(文書管理システム)の世界市場2015-2019About document management system Document management systems (DMS) enable organizations to manage tasks effectively and streamline processing of their documents across all departments. From unstructured content to structured documentation, DMS includes every action taken with respect to creation, distribution, and deletion of documents. It helps centralise unorganized documents. Unorganized conten …
- Namenda XR (Alzheimer’s Disease):市場予測と分析(~2022)Namenda XR (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Namenda XR (Alzheimer’s Disease) - Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic therapie …